风险投资
透视图(图形)
社会风险投资
首都(建筑)
业务
新产品开发
产品(数学)
企业风险投资
营销
生物技术
产业组织
财务
市场经济
经济
生物
地理
几何学
数学
考古
人工智能
计算机科学
出处
期刊:Elsevier eBooks
[Elsevier]
日期:2020-01-01
卷期号:: 287-298
标识
DOI:10.1016/b978-0-12-815585-1.00020-6
摘要
Venture capital (VC) has contributed a sizable percentage of the funds needed by development-stage biotechnology companies, especially for therapeutics at the later stages of product development and clinical testing when large amounts of capital are required. There are a wide range of VC firms that focus on different stages of development and various product sectors in the biotechnology industry. These VC funds are managed by professionals with diverse backgrounds and interests. Although there is limited capital available such that all worthy biotechnology ideas do not get funded, having a better understanding about VC partners interests and motivations will increase your likelihood of raising VC capital. In this chapter, we will share with you some background and insight from both a VC partner's and an entrepreneur's perspective that will improve your efforts to obtain capital for your company.
科研通智能强力驱动
Strongly Powered by AbleSci AI